TARS R&D to Revenue
Tarsus Pharmaceuticals Inc · R&D to Revenue
TARS R&D to Revenue
Latest reported14.25%period ending
TARS FY R&D/Revenue (0.00% → 14.25%)
Latest values, visible window
High-resolution chart · PNG
TARS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.2507% | |
| 29.1802% | |
| 288.3705% | |
| 165.1069% | |
| 73.1443% | |
| 0% | |
| 0% | |
| 0% |